Adverse events following immunization attributable to measles vaccine are rare.
Araki, Diane; Bruno, Judith; Salama, Peter; Sadeed, Abdul; Sadozai, Naveed; Nandy, Robin; Cairns, Lisa; Lievano, Fabio.
; 30(2): 270-2, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16689922
A randomized, controlled trial of an aerosolized vaccine against measles.
Estudo de soroconversão com formulações da vacina Biken CAM-70 contra sarampo.
Note de synthèse de l'OMS sur les vaccins contre la rougeole avril 2017.
The upsurge of SSPE--a reflection of national measles immunization status in Pakistan.
Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity.
Asymmetric regression models with limited responses with an application to antibody response to vaccine.
Multicenter Safety and Immunogenicity Trial of an Attenuated Measles Vaccine for NHP.
Vaccine platform recombinant measles virus.
Laboratory confirmation of measles in elimination settings: experience from the Republic of the Marshall Islands, 2003.
[IS A THIRD DOSE OF MEASLES VACCINE NECESSARY - AN IMMUNOLOGIST'S VIEW].